Skip to Content

Sodium thiosulfate Pregnancy and Breastfeeding Warnings

Sodium thiosulfate Pregnancy Warnings

Animal studies did not show embryotoxic or teratogenic effects. There are no controlled data in human pregnancy.

US FDA pregnancy category C: Animal reproduction studies have shown an adverse effect on the fetus and there are no adequate and well-controlled studies in humans, but potential benefits may warrant use of the drug in pregnant women despite potential risks.

This drug should be used during pregnancy only if the benefit outweighs the risk to the fetus.

AU TGA pregnancy category: Not formally assigned to a pregnancy category.
US FDA pregnancy category: C

Comments:
-Concerns about adverse effects on the fetus may have little relevance in the context of life threatening poisoning in the mother.

See references

Sodium thiosulfate Breastfeeding Warnings

Caution is recommended.

Excreted into human milk: Unknown
Excreted into animal milk: Data not available

Comments:
-Concerns about adverse effects on the breastfed infant may have little relevance in the context of life threatening poisoning in the mother.
-There is no information on when breastfeeding may be safely resumed after treatment.

See references

References for pregnancy information

  1. Cerner Multum, Inc. "Australian Product Information." O 0
  2. "Product Information. Sodium Thiosulfate (sodium thiosulfate)." American Regent Laboratories Inc, Shirley, NY.

References for breastfeeding information

  1. Cerner Multum, Inc. "Australian Product Information." O 0
  2. "Product Information. Sodium Thiosulfate (sodium thiosulfate)." American Regent Laboratories Inc, Shirley, NY.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide